Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-30.16	-316.66	-243.28
Graham Fair Price	-17.24	3.77	4.55
PEG	-48.17	1.82	3.52
Price/Book	-6.26	22.41	23.90
Price/Cash Flow	-69.25	327.82	-1066.09
Prices/Earnings	-41.68	-60.81	-42.92
Price/Sales	-7.37	34.11	36.83
Price/FCF	-69.25	327.82	-1066.09
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.00	0.77	0.78
Operating Margin	29.50	-0.14	-0.19
ROA	31.23	-0.03	-0.05
ROE	-0.14	-0.09	33.83
ROIC	-0.09	-0.07	25.32
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.15	-0.22	31.26
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.25	0.27	9.61
EPS QOQ	0.12	0.33	173.33
FCF QOQ	0.49	4.12	742.82
Revenue QOQ	0.09	0.03	-63.68
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	119.04	0.00	inf
Days Sales Outstanding (DSO)	61.06	46.88	-23.21
Inventory Turnover	0.76	0.00	inf
Debt/Capitalization	0.34	0.25	-26.47
Quick Ratio	0.87	0.82	-6.40
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.57	2.62	1.74
Cash	1.68	1.75	3.87
Capex	-0.01	-0.02	-72.85
Free Cash Flow	-0.06	0.18	210.18
Revenue	1.67	1.72	2.97
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.08	0.89	-17.45
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-1.70	1.00	-41.29
Naive Interpretation	Member

06 - Financial Health · Bad

Rating